Authors:
Bristow, RE
Duska, LR
Lambrou, NC
Fishman, EK
O'Neill, MJ
Trimble, EL
Montz, FJ
Citation: Re. Bristow et al., A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography, CANCER, 89(7), 2000, pp. 1532-1540
Authors:
Steller, MA
Egorin, MJ
Trimble, EL
Bartlett, DL
Zuhowski, EG
Alexander, HR
Dedrick, RL
Citation: Ma. Steller et al., A pilot phase I trial of continuous hyperthermic peritoneal perfusion withhigh-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer (vol 43, pg 106, 1999), CANC CHEMOT, 44(1), 1999, pp. 90-90
Authors:
Steller, MA
Egorin, MJ
Trimble, EL
Bartlett, DL
Zuhowski, EG
Alexander, HR
Dedrick, RL
Citation: Ma. Steller et al., A pilot phase I trial of continuous hyperthermic peritoneal perfusion withhigh-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer, CANC CHEMOT, 43(2), 1999, pp. 106-114
Citation: Tl. Cornelison et al., SEER data, corpus uteri cancer: Treatment trends versus survival for FIGO stage 11, 1988-1994, GYNECOL ONC, 74(3), 1999, pp. 350-355
Citation: El. Trimble, Clinical trials in ovarian cancer: are we doing our best?, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 31-32